ATE222122T1 - Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen - Google Patents

Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen

Info

Publication number
ATE222122T1
ATE222122T1 AT97916665T AT97916665T ATE222122T1 AT E222122 T1 ATE222122 T1 AT E222122T1 AT 97916665 T AT97916665 T AT 97916665T AT 97916665 T AT97916665 T AT 97916665T AT E222122 T1 ATE222122 T1 AT E222122T1
Authority
AT
Austria
Prior art keywords
immunotoxins
target cells
cell populations
cells
harvested cell
Prior art date
Application number
AT97916665T
Other languages
English (en)
Inventor
Oystein Fodstad
Gunnar Kvalheim
Siri Juell
Meng Yu Wang
Olav Engebraten
Original Assignee
Oystein Fodstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oystein Fodstad filed Critical Oystein Fodstad
Application granted granted Critical
Publication of ATE222122T1 publication Critical patent/ATE222122T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97916665T 1996-03-13 1997-03-12 Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen ATE222122T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO961031A NO961031D0 (no) 1996-03-13 1996-03-13 Fremgangsmåte til å drepe uönskede målceller
PCT/NO1997/000074 WO1997033611A1 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with one or more immunotoxins

Publications (1)

Publication Number Publication Date
ATE222122T1 true ATE222122T1 (de) 2002-08-15

Family

ID=19899150

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97916665T ATE222122T1 (de) 1996-03-13 1997-03-12 Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen

Country Status (18)

Country Link
US (1) US7198787B2 (de)
EP (1) EP0954329B1 (de)
JP (1) JP2000507230A (de)
CN (1) CN1218411A (de)
AT (1) ATE222122T1 (de)
AU (1) AU710184B2 (de)
BR (1) BR9708049A (de)
CA (1) CA2248620A1 (de)
DE (1) DE69714775T2 (de)
HU (1) HUP9901597A3 (de)
IL (1) IL126014A0 (de)
NO (1) NO961031D0 (de)
NZ (1) NZ331763A (de)
PL (1) PL328804A1 (de)
RU (1) RU2182493C2 (de)
SK (1) SK125798A3 (de)
TR (1) TR199801795T2 (de)
WO (1) WO1997033611A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2179862C1 (ru) * 2000-12-26 2002-02-27 Общество с ограниченной ответственностью Научно-производственный центр "МедБиоСпектр" Лекарственное средство для предотвращения отторжения трансплантата, моноклональное антитело к cd3-антигену т-лимфоцитов человека, гибридома и способ лечения больных, имеющих реакцию острого отторжения трансплантата после пересадки почки
RU2198681C2 (ru) * 2000-12-27 2003-02-20 Московский научно-исследовательский онкологический институт им. П.А. Герцена Моноклональное антитело ико25, специфичное к антигену мис1, противоопухолевое средство
GB0224442D0 (en) * 2002-10-21 2002-11-27 Molmed Spa A delivery system
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US7496291B2 (en) * 2006-03-21 2009-02-24 Hewlett-Packard Development Company, L.P. Method and apparatus for interleaved image captures
EP2029779A4 (de) 2006-06-14 2010-01-20 Living Microsystems Inc Verwendung hoch paralleler snp-genotypisierung zur fötalen diagnose
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
SMT201700149T1 (it) 2008-09-20 2017-05-08 Univ Leland Stanford Junior Diagnosi non invasiva di aneuploidia fetale mediante sequenziamento
RU2539832C2 (ru) 2008-10-17 2015-01-27 Дана-Фарбер Кэнсер Инститьют, Инк. Пептиды цитоплазматического домена белка muc-1 в качестве ингибиторов раковых заболеваний
AU2010253834B2 (en) 2009-05-27 2013-12-19 Dana-Farber Cancer Institute, Inc. Inhibition 0f inflammation using antagonists of MUC1
CN102127148B (zh) * 2010-01-14 2013-04-03 中国农业科学院北京畜牧兽医研究所 血管内皮细胞表面决定簇部分多肽及其应用
BR112013028537A2 (pt) * 2011-05-06 2017-01-17 Us Gov Health & Human Serv imunotoxina recombinante que visa a mesotelina
CN107748256B (zh) * 2017-10-11 2020-04-14 厦门骁科码生物科技有限公司 一种循环肿瘤细胞的液体活检检测方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219411A (en) 1978-09-18 1980-08-26 California Institute Of Technology Cell sorting apparatus
US4230685A (en) 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
US4510244A (en) 1980-04-17 1985-04-09 The Board Of Trustees Of The Leland Stanford Jr. University Cell labeling with antigen-coupled microspheres
AU563827B2 (en) 1982-07-01 1987-07-23 Millipore Corp. Filtration apparatus
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4704255A (en) 1983-07-15 1987-11-03 Pandex Laboratories, Inc. Assay cartridge
US4920061A (en) 1984-03-02 1990-04-24 The University Of Texas System Biological magnetic colloids
US4752569A (en) 1984-06-21 1988-06-21 The Regents Of The University Of California Sialylated Lewisx epitope, antibodies and diagnosis
US5019497A (en) 1984-11-09 1991-05-28 Lennart Olsson Human squamous lung carcinoma cell specific antigens and antibodies
US4710472A (en) 1985-09-25 1987-12-01 The United States Of America As Represented By The Secretary Of The Navy Magnetic separation device
US5076950A (en) 1985-12-20 1991-12-31 Syntex (U.S.A.) Inc. Magnetic composition for particle separation
JPS6345563A (ja) 1986-04-11 1988-02-26 Hitachi Ltd 細胞分析方法
US4895706A (en) 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US4857452A (en) 1986-12-04 1989-08-15 E. I. Du Pont De Nemours And Company Assay for carcinoma of breast, colon and ovary
RU2009500C1 (ru) * 1987-03-11 1994-03-15 Фармиталиа Карло Эрба С.Р.Л. Способ получения цитотоксического коньюгата
US5194300A (en) 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
US5322678A (en) * 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
US5256532A (en) 1988-05-02 1993-10-26 Zynaxis Technologies, Inc. Methods, reagents and test kits for determination of subpopulations of biological entities
FR2638848B1 (fr) 1988-11-04 1993-01-22 Chemunex Sa Procede de detection et/ou de dosage dans un milieu liquide ou semi-liquide d'au moins une substance organique, biologique ou medicamenteuse soluble, par une methode d'agglutination
ATE114507T1 (de) 1988-12-28 1994-12-15 Stefan Miltenyi Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
US5185254A (en) * 1988-12-29 1993-02-09 The Wistar Institute Gene family of tumor-associated antigens
GB8905001D0 (en) 1989-03-04 1989-04-19 Univ Leicester Screening for natural products of microbial metabolism
WO1990010692A1 (en) 1989-03-15 1990-09-20 University Of Florida Monoclonal antibody for use in detection and treatment of childhood leukemia
US5081030A (en) 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices
DE3919923A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
DE3919873A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
GB8916859D0 (en) 1989-07-24 1989-09-06 Dynal As Hapten linking
SU1698287A1 (ru) * 1989-10-31 1991-12-15 Всесоюзный онкологический научный центр АМН СССР Штамм гибридных культивируемых клеток животных MUS мUSсULUS L. - продуцент моноклонального антитела к антигену мембран жировых глобул женского молока
CA2072017A1 (en) * 1989-12-14 1991-06-15 David A. Scheinberg Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
GB8929297D0 (en) 1989-12-29 1990-02-28 Dynal As Method of separation
GB9007966D0 (en) 1990-04-09 1990-06-06 Dynal As Antigen/anti-antigen cleavage
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5340719A (en) 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
JPH05107249A (ja) 1991-02-04 1993-04-27 Toyobo Co Ltd リガンド・レセプター反応の高感度検出法
US5491068A (en) 1991-02-14 1996-02-13 Vicam, L.P. Assay method for detecting the presence of bacteria
AU2115092A (en) 1991-10-08 1993-04-22 Eastman Kodak Company Method, test device and kit for assay of specific binding ligand using controlled flow through filtration membrane
US5290707A (en) 1991-11-25 1994-03-01 The United States Of America As Represented By The Secretary Of The Army Method for detection of microorganisms
US5256542A (en) 1992-03-09 1993-10-26 Tanox Biosystems, Inc. Selecting low frequency antigen-specific single B lymphocytes with correction for background noise
ATE135050T1 (de) 1992-03-20 1996-03-15 Celsis Int Plc Verfahren und gerät zur analyse von biologischem material
US5422277A (en) 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
AU678179B2 (en) * 1992-07-28 1997-05-22 Steven Kessler Methods for positive immunoselection of stem cells
DK0723146T3 (da) 1992-09-14 2004-08-30 Stanford Res Inst Int Opkonverterende reportermolekyler til biologiske og andre assays ved anvendelse af laser-excitationsteknikker
WO1994007138A1 (en) 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
FR2700010B1 (fr) 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
US5374531A (en) 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
AUPN214095A0 (en) 1995-04-03 1995-04-27 Australian Water Technologies Pty Ltd Method for detecting microorganisms using flow cytometry

Also Published As

Publication number Publication date
NZ331763A (en) 2000-01-28
WO1997033611A1 (en) 1997-09-18
HUP9901597A2 (hu) 1999-08-30
CN1218411A (zh) 1999-06-02
US7198787B2 (en) 2007-04-03
RU2182493C2 (ru) 2002-05-20
BR9708049A (pt) 1999-07-27
CA2248620A1 (en) 1997-09-18
PL328804A1 (en) 1999-02-15
DE69714775T2 (de) 2003-04-24
DE69714775D1 (de) 2002-09-19
AU2522997A (en) 1997-10-01
IL126014A0 (en) 1999-05-09
EP0954329A1 (de) 1999-11-10
NO961031D0 (no) 1996-03-13
AU710184B2 (en) 1999-09-16
SK125798A3 (en) 1999-05-07
HUP9901597A3 (en) 2000-06-28
TR199801795T2 (xx) 1998-12-21
EP0954329B1 (de) 2002-08-14
US20020151689A1 (en) 2002-10-17
JP2000507230A (ja) 2000-06-13

Similar Documents

Publication Publication Date Title
DE69714775D1 (de) Verfahren zur Tötung von Zielzellen in geernteten Zellpopulationen mit Hilfe von zwei Immunotoxinen
DE60235464D1 (de) Knochenmarkersatzmaterial-verbundwerkstoff, verfahren zu seiner herstelllung und kit
DK0953046T3 (da) Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette
TW428026B (en) Bifunctional protein, preparation and use
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
EP1083828A4 (de) Biotechnisch erzeugte gefässprothese für die implantation
DK1019082T4 (da) Fremgangsmåde til moduleringen af neovaskularisering og/eller væksten af kollaterale arterier og/eller andre arterier fra forudeksisterende arteriolære forbindelser
EA200000298A1 (ru) Агонисты простагландинов и их применение для лечения заболеваний костей
AU9058091A (en) Preparation of nucleic acid samples
DE60043229D1 (de) Zusammensetzung zur gefässbeschichtung
AU3847100A (en) Method and kitset for sampling and storage of biological samples
ATE79720T1 (de) Verfahren zur konservierung von transplantierbaren, in vitro kultivierten epithelgeweben.
AU5419399A (en) Method for determining the immune defences of blood, test kit therefor and use of a suitable system for taking blood samples
DE69940753D1 (de) Verfahren zur Einführung von heterologischen Zellen in Fische
PT941329E (pt) Metodo para prevenir a rejeicao de enxertos em transplantacao e para produzir uma celula-hospedeiro para terapia genetica universal utilizando activacao de linfocitos (lag-3)
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
EP1304123A3 (de) Verfahren zur Modulierung des Wachstums kollateraler Arterien und / oder anderer Arterien aus bestehenden arteriolen Verbindungen
CA2517140A1 (en) Use of pc-cell derived growth factor (pcdgf) for increasing the proliferation of b cells
BR9712793A (pt) Fatores homólogos (fhfs) ao fator do desenvolvimento de fibroblasto e métodos de uso
DE69837212D1 (de) Verfahren zur induzierung der osteoblastischen differenzierung der zellen des menschlichen extramedullären fettgewebes
EP1728857A3 (de) Bereitstellung von Lebergewebe.
NO984175L (no) FremgangsmÕte til Õ drepe mÕlceller i h°stede cellepopulasjoner med en eller flere immunotoksiner
WO2000036420A3 (en) Differential expression in primary breast cancer
EP1826560A3 (de) Verfahren zur Einführung von heterologischen Zellen in Fische

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties